Diclofenac Sodium and MisoprostolDelayed-Release (Dash Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Diclofenac Sodium and Misoprostol drug offered from Dash Pharmaceuticals LLC. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dash Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | Diclofenac Sodium and Misoprostol |
SUBSTANCE NAME: | DICLOFENAC SODIUM; MISOPROSTOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-02-18 |
END MARKETING DATE: | 0000-00-00 |
Diclofenac Sodium and Misoprostol Delayed-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Diclofenac Sodium and Misoprostol Delayed-Release from Dash Pharmaceuticals LLC |
LABELER NAME: | Dash Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; .2(mg/1; mg/1) |
START MARKETING DATE: | 2015-02-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69339-123_e04ae685-2d0f-44e6-9252-3c27d7dec863 |
PRODUCT NDC: | 69339-123 |
APPLICATION NUMBER: | ANDA200540 |
Other DICLOFENAC SODIUM; MISOPROSTOL Pharmaceutical Manufacturers / Labelers: